Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$328M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Target
TGT
|
+$155M |
| 5 |
Walt Disney
DIS
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.03% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.92% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Destination XL Group
DXLG
$32.9M
| $157K | ﹤0.01% |
+24,300
| New | +$156K |
|
2627
Opko Health
OPK
$1.02B
| $157K | ﹤0.01% |
+17,802
| New | +$143K |
|
|
FAC
2628
DELISTED
First Acceptance Corp.
FAC
| $156K | ﹤0.01% |
89,300
+9,900
| +12% | +$17.3K |
|
|
WG
2629
DELISTED
Willbros Group
WG
| $154K | ﹤0.01% |
16,800
-73,700
| -81% | -$619K |
|
|
PQUE
2630
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
| $153K | ﹤0.01% |
38,254
-80,400
| -68% | -$322K |
|
|
FST
2631
DELISTED
FOREST OIL CORPORATION
FST
| $152K | ﹤0.01% |
24,895
-3,116,300
| -99% | -$16.7M |
|
2632
CBAK Energy Technology Ltd
CBAT
$43.1M
| $151K | ﹤0.01% |
64,940
+30,700
| +90% | +$52K |
|
|
MICR
2633
DELISTED
Micron Solutions, Inc.
MICR
| $151K | ﹤0.01% |
56,100
| – | – |
|
2634
MakeMyTrip
MMYT
$5.38B
| $150K | ﹤0.01% |
+10,100
| New | +$139K |
|
|
ORKA
2635
Oruka Therapeutics
ORKA
$5.31B
| $150K | ﹤0.01% |
62
+52
| +520% | +$108K |
|
|
QCCO
2636
DELISTED
QC HLDGS INC
QCCO
| $149K | ﹤0.01% |
64,200
+4,000
| +7% | +$10.2K |
|
2637
Codexis
CDXS
$158M
| $148K | ﹤0.01% |
84,100
-74,800
| -47% | -$156K |
|
2638
Clear Channel Outdoor Holdings
CCO
$1.22B
| $147K | ﹤0.01% |
+17,900
| New | +$137K |
|
|
BSPM
2639
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
| $147K | ﹤0.01% |
28,053
+1,100
| +4% | +$6.03K |
|
|
NURO
2640
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $145K | ﹤0.01% |
34
-2
| -6% | -$8.84K |
|
2641
Ultralife
ULBI
$88.3M
| $144K | ﹤0.01% |
36,000
-2,500
| -6% | -$9.42K |
|
2642
Cadiz
CDZI
$251M
| $143K | ﹤0.01% |
28,000
+5,700
| +26% | +$27.4K |
|
|
GUID
2643
DELISTED
Guidance Software, Inc.
GUID
| $141K | ﹤0.01% |
15,600
-25,800
| -62% | -$226K |
|
2644
Aehr Test Systems
AEHR
$2.13B
| $140K | ﹤0.01% |
59,000
+9,300
| +19% | +$15.7K |
|
|
ENG
2645
DELISTED
ENGlobal Corp
ENG
| $139K | ﹤0.01% |
17,863
+2,363
| +15% | +$20.6K |
|
|
AUD
2646
DELISTED
Audacy, Inc.
AUD
| $139K | ﹤0.01% |
+15,800
| New | +$147K |
|
|
PW
2647
Power REIT
PW
$3.25M
| $137K | ﹤0.01% |
1,610
-310
| -16% | -$26.1K |
|
|
KID
2648
DELISTED
KID BRANDS,INC COMMON STOCK
KID
| $137K | ﹤0.01% |
92,900
+1,700
| +2% | +$2.51K |
|
|
TECUB
2649
DELISTED
TECUMSEH PRODUCTS CO CL-B
TECUB
| $136K | ﹤0.01% |
15,700
+3,800
| +32% | +$32.9K |
|
|
BLRX
2650
BioLineRX
BLRX
$12M
| $135K | ﹤0.01% |
103
+53
| +106% | +$62.6K |
|
Similar funds
Renaissance Technologies's Q3 2013 Portfolio in Review
As of Q3 2013, Renaissance Technologies held 3,196 positions worth $41.2B, up 8.1% from $38.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q3 2013 filing shows 439 new, 1,284 increased, 1,031 reduced and 412 closed positions. Its largest new stake was GE Aerospace: 1,361,721 shares worth $156M. The largest sale was Apple, an estimated $283M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q3 2013 buy was GE Aerospace: 1,361,721 shares worth $156M.
- Renaissance Technologies added most to IBM in Q3 2013, an estimated $328M increase.
- Renaissance Technologies's biggest Q3 2013 reduction was Eli Lilly, cutting an estimated $211M.
- Renaissance Technologies fully exited Apple in Q3 2013, selling an estimated $283M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.2B portfolio in Q3 2013.
- Renaissance Technologies opened 439 new positions and closed 412 in Q3 2013.
- Renaissance Technologies's portfolio value rose 8.1% quarter-over-quarter to $41.2B.
Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.